Search results for "Rigaku Analytical Devices"
Selected Filters:
ROHS Rapid Screening by Benchtop XRF
NEX QC+ QuantEZ
Rigaku CorporationHigh performance benchtop EDXRF spectrometer with Windows® software.
ZSX Primus IV - Tube-above Wavelength Dispersive X-ray Fluorescence Spectrometer
Rigaku CorporationHigh performance WDXRF for rapid quantitative elemental analysis
PAL RSI and PAL RTC - Sample prep and injection
A reference notebook of microwave applications
Fusion Antibodies partners with Eurofins Discovery to support innovative preclinical drug discovery research
Fusion Antibodies and Eurofins Discovery sign co-marketing agreement to support timely and cost-effective development of innovative products for the benefit of global healthcare.
Thermo Scientific™ Cell Locker™ System and Accessory
Thermo Fisher ScientificProtected chambers for your most sensitive cells. Thermo Scientific™ Cell Locker™ System and Chambers provide enhanced protection and more stability. They segregate cell types, projects or user areas and are ideal for sensitive cells and/or shared incubators.
Breakthrough protein analysis instrument – the Fluidity One-W – launches at PEGS Europe 2019
Accurate and detailed protein interactions analysis under near-native conditions with an easy-to-use system
A flexible approach to phase II-IV clinical trials
Analysis of protein interactions using proximity-based BRET assays
Can the Tristar2 S LB 942 be used to analyze protein interactions?
Uniqsis launches a new high intensity photochemistry light source
New Borealis LED light source has shown to accelerate photoredox catalysis
Insitec Dry Online Particle Size Analyzer
Malvern PanalyticalThe industrially robust, technologically proven process particle size analyzer
Portable Spectrometer for Field Applications
eTheRNA announces new LNP formulation development and production service
The service aims to support the discovery and early pre-clinical development of RNA-based therapeutics and vaccines.
SAGA Diagnostics enters into assay development agreement with AstraZeneca
Under the new agreement, unique SAGAsafe dPCR assays will be developed for the analysis of tissue samples and liquid biopsies